메뉴 건너뛰기




Volumn 103, Issue 4, 2017, Pages 307-314

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2,927)  Camm, A John a   Accetta, Gabriele b   Ambrosio, Giuseppe c   Atar, Dan d,e   Bassand, Jean Pierre f   Berge, Eivind d   Cools, Frank g   Fitzmaurice, David A h   Goldhaber, Samuel Z i   Goto, Shinya j   Haas, Sylvia k   Kayani, Gloria b   Koretsune, Yukihiro l   Mantovani, Lorenzo G m   Misselwitz, Frank n   Oh, Seil o   Turpie, Alexander G G p   Verheugt, Freek W A q   Kakkar, Ajay K b,r   Hacke, Werner s   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT;

EID: 84988528864     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-309832     Document Type: Article
Times cited : (215)

References (30)
  • 1
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 3
    • 84868523625 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • CammAJ,LipGY,DeCaterinaR,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-47.
    • (2012) Eur Heart J , vol.33 , pp. 2719-2747
    • Camm, A.J.1    Lip, G.Y.2    DeCaterina, R.3
  • 4
    • 84916925479 scopus 로고    scopus 로고
    • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society
    • January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:e199-267.
    • (2014) Circulation , vol.130 , pp. e199-e267
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3
  • 5
    • 84858595913 scopus 로고    scopus 로고
    • Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: Recommendations for stroke prevention and rate/rhythm control
    • SkanesAC,HealeyJS,CairnsJA,et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012;28: 125-36.
    • (2012) Can J Cardiol , vol.28 , pp. 125-136
    • Skanes, A.C.1    Healey, J.S.2    Cairns, J.A.3
  • 6
    • 77953851760 scopus 로고    scopus 로고
    • Underuse of oral anticoagulants in atrial fibrillation: A systematic review
    • Ogilvie IM, Newton N, Welner SA, et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123:638-45.e4.
    • (2010) Am J Med , vol.123 , pp. 638-638e4
    • Ogilvie, I.M.1    Newton, N.2    Welner, S.A.3
  • 7
    • 54949116895 scopus 로고    scopus 로고
    • Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
    • 863.e2
    • Goto S, Bhatt DL, Röther J, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855-63, 863.e2.
    • (2008) Am Heart J , vol.156 , pp. 855-863
    • Goto, S.1    Bhatt, D.L.2    Röther, J.3
  • 8
    • 79957855883 scopus 로고    scopus 로고
    • Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: A report from the J-RHYTHM Registry
    • Atarashi H, Inoue H, Okumura K, et al. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011;75:1328-33.
    • (2011) Circ J , vol.75 , pp. 1328-1333
    • Atarashi, H.1    Inoue, H.2    Okumura, K.3
  • 9
    • 84856208945 scopus 로고    scopus 로고
    • Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: Results from the AVAIL Registry
    • Lopes RD, Shah BR, Olson DM, et al. Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry. Stroke 2011;42:3477-83.
    • (2011) Stroke , vol.42 , pp. 3477-3483
    • Lopes, R.D.1    Shah, B.R.2    Olson, D.M.3
  • 10
    • 35248891927 scopus 로고    scopus 로고
    • National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing
    • Mahmud A, Bennett K, Okechukwu I, et al. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing. Br J Clin Pharmacol 2007;64:706-9.
    • (2007) Br J Clin Pharmacol , vol.64 , pp. 706-709
    • Mahmud, A.1    Bennett, K.2    Okechukwu, I.3
  • 11
    • 33845718250 scopus 로고    scopus 로고
    • Antithrombotic treatment in real-life atrial fibrillation patients: A report from the Euro Heart Survey on Atrial Fibrillation
    • Nieuwlaat R, Capucci A, Lip GY, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006;27:3018-26.
    • (2006) Eur Heart J , vol.27 , pp. 3018-3026
    • Nieuwlaat, R.1    Capucci, A.2    Lip, G.Y.3
  • 12
    • 83555164615 scopus 로고    scopus 로고
    • International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
    • Kakkar AK, Mueller I, Bassand JP, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J 2012;163:13-19.e1.
    • (2012) Am Heart J , vol.163 , pp. 13-13e1
    • Kakkar, A.K.1    Mueller, I.2    Bassand, J.P.3
  • 13
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-266.
    • (2002) Am J Kidney Dis , vol.39 , pp. S1-S266
  • 14
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263-72.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3
  • 15
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100.
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3
  • 16
    • 34347407592 scopus 로고    scopus 로고
    • Multiple imputation of discrete and continuous data by fully conditional specification
    • van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219-42.
    • (2007) Stat Methods Med Res , vol.16 , pp. 219-242
    • Van Buuren, S.1
  • 17
    • 0002344593 scopus 로고    scopus 로고
    • A multivariate technique for multiply imputing missing values using a sequence of regression models
    • Raghunathan TE, Lepkowski JM, Van Hoewyk J, et al. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodol 2001;85:85-95.
    • (2001) Survey Methodol , vol.85 , pp. 85-95
    • Raghunathan, T.E.1    Lepkowski, J.M.2    Van Hoewyk, J.3
  • 18
    • 84882453013 scopus 로고    scopus 로고
    • The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation
    • Ogawa S, Aonuma K, Tse HF, et al. The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation. J Arrhythm 2013;29:190-200.
    • (2013) J Arrhythm , vol.29 , pp. 190-200
    • Ogawa, S.1    Aonuma, K.2    Tse, H.F.3
  • 19
    • 84856745317 scopus 로고    scopus 로고
    • Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141: e531S-75S.
    • (2012) Chest , vol.141 , pp. e531S-e575S
    • You, J.J.1    Singer, D.E.2    Howard, P.A.3
  • 20
    • 78349242121 scopus 로고    scopus 로고
    • Guidelines for pharmacotherapy of atrial fibrillation ( JCS 2008): Digest version
    • JCS Joint Working Group
    • JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation ( JCS 2008): digest version. Circ J 2010;74:2479-500.
    • (2010) Circ J , vol.74 , pp. 2479-2500
  • 21
    • 79953332012 scopus 로고    scopus 로고
    • Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    • Cairns JA, Connolly S, McMurtry S, et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol 2011;27:74-90.
    • (2011) Can J Cardiol , vol.27 , pp. 74-90
    • Cairns, J.A.1    Connolly, S.2    McMurtry, S.3
  • 22
    • 84907965406 scopus 로고    scopus 로고
    • 2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation
    • Verma A, Cairns JA, Mitchell LB, et al. 2014 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol 2014;30:1114-30.
    • (2014) Can J Cardiol , vol.30 , pp. 1114-1130
    • Verma, A.1    Cairns, J.A.2    Mitchell, L.B.3
  • 23
    • 84942373295 scopus 로고    scopus 로고
    • Implementing guidelines: The cost and clinical impact of anticoagulants in the UK atrial fibrillation population
    • Shields GE, Bates AE, Chapman AM. Implementing guidelines: the cost and clinical impact of anticoagulants in the UK atrial fibrillation population. Appl Health Econ Health Policy 2015;13:543-51.
    • (2015) Appl Health Econ Health Policy , vol.13 , pp. 543-551
    • Shields, G.E.1    Bates, A.E.2    Chapman, A.M.3
  • 24
    • 84941023409 scopus 로고    scopus 로고
    • A health economic evaluation of stroke prevention in atrial fibrillation: Guideline adherence versus the observed treatment strategy prior to 2012 in Denmark
    • Vestergaard AS, Ehlers LH. A health economic evaluation of stroke prevention in atrial fibrillation: guideline adherence versus the observed treatment strategy prior to 2012 in Denmark. Pharmacoeconomics 2015;33:967-79.
    • (2015) Pharmacoeconomics , vol.33 , pp. 967-979
    • Vestergaard, A.S.1    Ehlers, L.H.2
  • 25
    • 84942123297 scopus 로고    scopus 로고
    • Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
    • Lip GY, Rushton-Smith SK, Goldhaber SZ, et al. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: the prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circ Cardiovasc Qual Outcomes 2015;8:S12-20.
    • (2015) Circ Cardiovasc Qual Outcomes , vol.8 , pp. S12-S20
    • Lip, G.Y.1    Rushton-Smith, S.K.2    Goldhaber, S.Z.3
  • 26
    • 84873569160 scopus 로고    scopus 로고
    • Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
    • Dans AL, Connolly SJ, Wallentin L, et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 2013;127:634-40.
    • (2013) Circulation , vol.127 , pp. 634-640
    • Dans, A.L.1    Connolly, S.J.2    Wallentin, L.3
  • 27
    • 78349313002 scopus 로고    scopus 로고
    • Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: A subgroup analysis of the RE-LY trial
    • Diener HC, Connolly SJ, Ezekowitz MD, et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol 2010;9:1157-63.
    • (2010) Lancet Neurol , vol.9 , pp. 1157-1163
    • Diener, H.C.1    Connolly, S.J.2    Ezekowitz, M.D.3
  • 28
    • 84856842909 scopus 로고    scopus 로고
    • Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A predefined subgroup analysis from AVERROES, a randomised trial
    • Diener HC, Eikelboom J, Connolly SJ, et al. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol 2012;11:225-31.
    • (2012) Lancet Neurol , vol.11 , pp. 225-231
    • Diener, H.C.1    Eikelboom, J.2    Connolly, S.J.3
  • 29
    • 84861198376 scopus 로고    scopus 로고
    • Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the Aristotle trial
    • Easton JD, Lopes RD, Bahit MC, et al. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol 2012;11:503-11.
    • (2012) Lancet Neurol , vol.11 , pp. 503-511
    • Easton, J.D.1    Lopes, R.D.2    Bahit, M.C.3
  • 30
    • 84858621485 scopus 로고    scopus 로고
    • Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of ROCKET AF
    • Hankey GJ, Patel MR, Stevens SR, et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol 2012;11:315-22.
    • (2012) Lancet Neurol , vol.11 , pp. 315-322
    • Hankey, G.J.1    Patel, M.R.2    Stevens, S.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.